Xiao Zhao

机构：Sun Yat-sen University, Chinese PLA General Hospital, The First Affiliated Hospital, Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0000-0002-8661-1480

发表论文 6 篇 · 总被引 256 次 · h-index 4

代表论文

• Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation (2022 · Hepatology · 被引 175)
• Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma (2024 · JAMA Oncology · 被引 59)
• Proteoglycan-4 predicts good prognosis in patients with hepatocellular carcinoma receiving transcatheter arterial chemoembolization and inhibits cancer cell migration in vitro (2022 · Frontiers in Oncology · 被引 10)
• Correlation of Serum Chemokine Ligand 14 with Barcelona Clinic Liver Cancer Stage, Lymphocyte Profile, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma (2023 · Journal of Vascular and Interventional Radiology · 被引 5)
• DEB ‐ TACE versus cTACE for unresectable HCC with B1 ‐type bile duct invasion after successful biliary drainage: A propensity score matching analysis (2024 · Cancer Medicine · 被引 4)
• The Tumor Microenvironment and Tumor-infiltrating Lymphocytes in Solid Tumor: A Comprehensive Review (2024 · Oncology Advances · 被引 3)